Shire (SHPG) Announces Receipt of Positive CHMP Opinion on ONIVYDE as Metastatic Adenocarcinoma Treatment
Tweet Send to a Friend
Shire plc (Nasdaq: SHPG) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE